The Lahey Clinic, Boston, Mass. Read at the annual meeting of the New England Surgical Society, at Scarboro, Maine, September 12, 1931. Select the format you want to export the citation of this ...

1). The company’s lead hepatic program, OLX702A, is being developed for the treatment of NASH, a common liver disease characterized by the accumulation of liver fat, inflammation, and ...

Most coagulation factors increase during pregnancy, and low levels of fibrin-split products (ie, < 40 U) are common in late pregnancy ... have been used to estimate hepatic blood flow.